Searching for Protein Off-Targets of Prostate-Specific Membrane Antigen-Targeting Radioligands in the Salivary Glands
Cancer Biotherapy and Radiopharmaceuticals · 2024
DOI: 10.1089/cbr.2024.0066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von William Julian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Radiology Department, Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Salivary Glands, Glutamate Carboxypeptidase II, Radiopharmaceuticals. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Prostate specific membrane antigen (PSMA)-targeted radioligand therapies represent a highly effective treatment for metastatic prostate cancer. However, high and sustain uptake of PSMA-ligands in the salivary glands led to dose limiting dry mouth (xerostomia), especially with α-emitters. The expression of PSMA and histologic analysis couldn't directly explain the toxicity, suggesting a potential off-target mediator for uptake. In this study, we searched for possible off-target non-PSMA protein(s) in the salivary glands.
Methods
A machine-learning based quantitative structure activity relationship (QSAR) model was built for seeking the possible off-target(s). The resulting target candidates from the model prediction were subjected to further analysis for salivary protein expression and structural homology at key regions required for PSMA-ligand binding. Furthermore, cellular binding assays were performed utilizing multiple cell lines with high expression of the candidate proteins and low expression of PSMA. Finally, PSMA knockout (PSMA-/-) mice were scanned by small animal PET/MR using [68Ga]Ga-PSMA-11 for in-vivo validation.
Results
The screening of the trained QSAR model did not yield a solid off-target protein, which was corroborated in part by cellular binding assays. Imaging using PSMA-/- mice further demonstrated markedly reduced PSMA-radioligand uptake in the salivary glands.
Conclusion
Uptake of the PSMA-targeted radioligands in the salivary glands remains primarily PSMA-mediated. Further investigations are needed to illustrate a seemingly different process of uptake and retention in the salivary glands than that in prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Radiology Department, Case Western Reserve University, Cleveland, Ohio, USA.
- Biomedical Engineering Department, Case Western Reserve University, Cleveland, Ohio, USA.
- Nutrition Department, Case Western Reserve University, Cleveland, Ohio, USA.
ORCID-Profile: Zhenghong Lee
Förderung
- NIGMS NIH HHS
- NIH HHS
Zitieren
APA
Julian, W., Sergeeva, O., Cao, W., Wu, C., Erokwu, B., Flask, C., Zhang, L., Wang, X., Basilion, J., Yang, S., & Lee, Z. (2024). Searching for Protein Off-Targets of Prostate-Specific Membrane Antigen-Targeting Radioligands in the Salivary Glands. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2024.0066
Vancouver
Julian W, Sergeeva O, Cao W, Wu C, Erokwu B, Flask C, et al. Searching for Protein Off-Targets of Prostate-Specific Membrane Antigen-Targeting Radioligands in the Salivary Glands. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2024.0066
BibTeX
@article{Julian2024,
author = {Julian, William and Sergeeva, Olga and Cao, Wei and Wu, Chunying and Erokwu, Bernadette and Flask, Chris and Zhang, Lifang and Wang, Xinning and Basilion, James and Yang, Sichun and Lee, Zhenghong},
title = {Searching for Protein Off-Targets of Prostate-Specific Membrane Antigen-Targeting Radioligands in the Salivary Glands},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2024},
doi = {10.1089/cbr.2024.0066}
}
EUVIMED